A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management by Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani

Subjects: Get full text

Dual-radiomics based on SHapley additive explanations for predicting hematologic toxicity in concurrent chemoradiotherapy patients by Luqiao Chen, Zhipeng He, Qianxi Ni, Qionghui Zhou, Xizi Long, Wenbin Yan, Qian Sui, Jiheng Liu

Subjects: “…Hematologic toxicity…”
Get full text

Radiation hematologic toxicity prediction in rectal cancer: a comparative radiomics-based study on CT image and dose map by Yingpeng Liu, Liping Guo, Yi Wang, Qingtao Xu, Jingfeng Zhang, Xianyun Meng

Subjects: Get full text

Combined clinical and MRI-based radiomics model for predicting acute hematologic toxicity in gynecologic cancer radiotherapy by Lumeng Luo, Lumeng Luo, Jiahao Wang, Jiahao Wang, Hongling Xie, Hongling Xie, Bingxin Chen, Bingxin Chen, Hui Wang, Hui Wang, Qiu Tang, Qiu Tang

Subjects: “…hematologic toxicity…”
Get full text

Prevention of neutropenia as an important factor in successful chemotherapy for head and neck cancer by L. G. Babicheva, S. O. Podvyaznikov

Subjects: Get full text

Hybrid deep learning enables multi-institutional delineation of active bone marrow for gynecologic radiotherapy by Zhe Zhang, Xiao Lu, Sicheng He, Tao Huang, Shaobin Wang, Mingjun Lu, Xiaomin Zhang, Zhibo Tan, John Moraros, Lei Zhang, Xin Li, Zhan Li, Zihao Deng, Yimeng Zhang, Mengjie Dong, Shuihua Wang, Yajie Liu

Subjects: Get full text

The characteristics of side effects of different modes of chemotherapy for breast cancer by Bondarenko I.M., Phokhach A.V.

Subjects: Get full text

The characteristics of side effects of different modes of chemotherapy for breast cancer. by I. M. Bondarenko, A. V. Phokhach

Subjects: Get full text

Renal function affects the plasma concentration and hematological toxicity of linezolid in elderly patients: a propensity-matched cohort analysis by Bing Liu, Guangrui Geng, Tingting Liu, Lingli Zhou, Fang Wang, Ping Yang, Jiaxin Liu, Junshuai Zhao, Cheng Zhao, Yue Wang, Minna Yang, Jing Fu, Jingyue Chen, Xiaomin Chen, Xiangqun Fang, Lixin Xie, Hongxia Li

Subjects: Get full text

Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database by Yamin Shu, Yufeng Ding, Xucheng He, Yanxin Liu, Pan Wu, Qilin Zhang

Subjects: Get full text

Immunocorrective treatment use in the prevention of hematological and infectious complications of chemotherapy in cancer patients by L. Yu. Grivtsova, V. B. Larionova, N. A. Falaleeva

Subjects: Get full text

The role of pomalidomide in treatment of relapse and refractory multiple myeloma by S. V. Voloshin, S. Yu. Linnikov, A. D. Garifullin, A. A. Kuzyaeva, A. V. Shmidt, A. Yu. Kuvshinov, A. N. Bogdanov, M. A. Mikhileva, I. S. Martynkevich, M. N. Zenina, S. V. Sidorkevich

Subjects: Get full text

Efficacy and prognostic analysis of venetoclax combined with hypomethylating agents for induction therapy in acute myeloid leukemia: a multi-center real-world study on indication-s... by Leiming Xia, Mengni Qu, Ling Ge, Yingying Chen, Beibei Zhou, Ting Shi, Yang Liu, Min Ruan, Liang Xia, Jian Hong, Jianjun Li, Wei Qian, Yu Zhang, Lei Jiang, Yiming Zhao, Wanlu Tian, Zhenqi Huang, Fengbo Jin, Jian Ge, Mingzhen Yang, Qingshu Zeng

Subjects: Get full text

New insights into CAR T-cell hematological toxicities: manifestations, mechanisms, and effective management strategies by Yuanyuan Yang, Hongwei Peng, Jianxiang Wang, Fei Li

Subjects: Get full text

Effect of trilaciclib administered before chemotherapy in patients with extensive-stage small-cell lung cancer: A pooled analysis of four randomized studies by Ying Liu, Lin Wu, Dingzhi Huang, Qiming Wang, Chen Yang, Li Zhou, Shuguang Sun, Xiaomei Jiang, Ying Cheng

Subjects: Get full text

Dosimetric and hematological toxicity analyses of bone marrow‐sparing intensity‐modulated radiation therapy for patients with cervical cancer treated with extended‐field radiation... by Jia‐nan Wang, Xi Yu, Li‐na Gu, Dong‐mei Liu, Qiu‐yue Su, Jing‐qi Xia, Wei‐Kang Yun, Xin Li, Xue‐Yuan Hu, Shan‐Shan Yang, De‐Yang Yu

Subjects: Get full text

Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia by E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin

Subjects: Get full text

Hematological Side Effects of ¹⁷⁷Lu-DOTA-TATE Therapy in Patients with NENs by Luciano Carideo, Rosaria Meucci, Giuseppe Campagna, Vincenzo Marcello Russo, Enrico D’Ippolito, Maria Rinzivillo, Francesco Panzuto, Daniela Prosperi

Subjects: “…hematological toxicity…”
Get full text